ERBB2 and neoplasm: This study shows that Natural Killer cells that infiltrate the tumor (TI-NK) produce CCL5 and IFN-ɣ upon activation, triggering the development of an effective anti-tumor immune response along anti-HER2 antibody-based neoadjuvant treatment.